Records containing: Lennox-Gastaut Syndrome (LGS)

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2026-03-19
  A Phase 2, Prospective, Interventional, Open-Label, Multi-Site, Extension Study to Assess the Long-Term Safety and Tolerability of Soticlestat (TAK-935) as Adjunctive Therapy in Subjects With Developmental Epileptic Encephalopathies Including Dravet Syndrome, Lennox Gastaut Syndrome, CDKL5 Deficiency Disorder, and Chromosome 15 Duplication Syndrome (ENDYMION 1)
• CLINICAL_TRIALS study record update · 2026-03-17
  A Clinical Study of the Transition of Children From 'Artisanal' Cannabidiol to Epidiolex
• CLINICAL_TRIALS study record update · 2025-04-17
  Epidemiology of Dravet and Lennox-Gastaut Syndromes in Spain
• CLINICAL_TRIALS study record update · 2025-03-06
  An Open-label, Nonrandomized, Phase 3 Study to Evaluate the Efficacy and Safety of Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine
• CLINICAL_TRIALS study record update · 2024-12-18
  Preliminary Evaluation of the Safety and Efficacy of CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in Individuals Diagnosed with Dravet Syndrome And/or Lennox-Gastaut Syndrome
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2024-10-03
  Epidemiology of Dravet and Lennox-Gastaut Syndromes in Portugal
• CLINICAL_TRIALS study record update · 2022-03-09
  A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase of Perampanel as Adjunctive Treatment in Subjects at Least 2 Years of Age With Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome